682 related articles for article (PubMed ID: 23775842)
41. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
[TBL] [Abstract][Full Text] [Related]
42. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
Purzner T; Purzner J; Buckstaff T; Cozza G; Gholamin S; Rusert JM; Hartl TA; Sanders J; Conley N; Ge X; Langan M; Ramaswamy V; Ellis L; Litzenburger U; Bolin S; Theruvath J; Nitta R; Qi L; Li XN; Li G; Taylor MD; Wechsler-Reya RJ; Pinna LA; Cho YJ; Fuller MT; Elias JE; Scott MP
Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206138
[TBL] [Abstract][Full Text] [Related]
43. Disruption of rack1 suppresses SHH-type medulloblastoma formation in mice.
Liu F; Shao J; Yang H; Yang G; Zhu Q; Wu Y; Zhu L; Wu H
CNS Neurosci Ther; 2021 Dec; 27(12):1518-1530. PubMed ID: 34480519
[TBL] [Abstract][Full Text] [Related]
44. Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma.
Vaillant C; Valdivieso P; Nuciforo S; Kool M; Schwarzentruber-Schauerte A; Méreau H; Cabuy E; Lobrinus JA; Pfister S; Zuniga A; Frank S; Zeller R
PLoS One; 2015; 10(4):e0124870. PubMed ID: 25901736
[TBL] [Abstract][Full Text] [Related]
45. The Shh receptor Boc promotes progression of early medulloblastoma to advanced tumors.
Mille F; Tamayo-Orrego L; Lévesque M; Remke M; Korshunov A; Cardin J; Bouchard N; Izzi L; Kool M; Northcott PA; Taylor MD; Pfister SM; Charron F
Dev Cell; 2014 Oct; 31(1):34-47. PubMed ID: 25263791
[TBL] [Abstract][Full Text] [Related]
46. Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration.
Yuan L; Zhang H; Liu J; Rubin JB; Cho YJ; Shu HK; Schniederjan M; MacDonald TJ
Mol Cancer; 2013 Mar; 12():18. PubMed ID: 23497290
[TBL] [Abstract][Full Text] [Related]
47. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ
Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586
[TBL] [Abstract][Full Text] [Related]
48. TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma.
Hellwig M; Lauffer MC; Bockmayr M; Spohn M; Merk DJ; Harrison L; Ahlfeld J; Kitowski A; Neumann JE; Ohli J; Holdhof D; Niesen J; Schoof M; Kool M; Kraus C; Zweier C; Holmberg D; Schüller U
Acta Neuropathol; 2019 Apr; 137(4):657-673. PubMed ID: 30830316
[TBL] [Abstract][Full Text] [Related]
49. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem.
Grammel D; Warmuth-Metz M; von Bueren AO; Kool M; Pietsch T; Kretzschmar HA; Rowitch DH; Rutkowski S; Pfister SM; Schüller U
Acta Neuropathol; 2012 Apr; 123(4):601-14. PubMed ID: 22349907
[TBL] [Abstract][Full Text] [Related]
50. Na,K-ATPase β1-subunit is a target of sonic hedgehog signaling and enhances medulloblastoma tumorigenicity.
Lee SJ; Litan A; Li Z; Graves B; Lindsey S; Barwe SP; Langhans SA
Mol Cancer; 2015 Aug; 14():159. PubMed ID: 26286140
[TBL] [Abstract][Full Text] [Related]
51. Smurf1 and Smurf2 mediated polyubiquitination and degradation of RNF220 suppresses Shh-group medulloblastoma.
Li Y; Wang H; Sun B; Su G; Cang Y; Zhao L; Zhao S; Li Y; Mao B; Ma P
Cell Death Dis; 2023 Aug; 14(8):494. PubMed ID: 37537194
[TBL] [Abstract][Full Text] [Related]
52. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.
Brun SN; Markant SL; Esparza LA; Garcia G; Terry D; Huang JM; Pavlyukov MS; Li XN; Grant GA; Crawford JR; Levy ML; Conway EM; Smith LH; Nakano I; Berezov A; Greene MI; Wang Q; Wechsler-Reya RJ
Oncogene; 2015 Jul; 34(29):3770-9. PubMed ID: 25241898
[TBL] [Abstract][Full Text] [Related]
53. Druggable glycolytic requirement for Hedgehog-dependent neuronal and medulloblastoma growth.
Di Magno L; Manzi D; D'Amico D; Coni S; Macone A; Infante P; Di Marcotullio L; De Smaele E; Ferretti E; Screpanti I; Agostinelli E; Gulino A; Canettieri G
Cell Cycle; 2014; 13(21):3404-13. PubMed ID: 25485584
[TBL] [Abstract][Full Text] [Related]
54. Basal Suppression of the Sonic Hedgehog Pathway by the G-Protein-Coupled Receptor Gpr161 Restricts Medulloblastoma Pathogenesis.
Shimada IS; Hwang SH; Somatilaka BN; Wang X; Skowron P; Kim J; Kim M; Shelton JM; Rajaram V; Xuan Z; Taylor MD; Mukhopadhyay S
Cell Rep; 2018 Jan; 22(5):1169-1184. PubMed ID: 29386106
[TBL] [Abstract][Full Text] [Related]
55. Multifaceted Functions of Rab23 on Primary Cilium-Mediated and Hedgehog Signaling-Mediated Cerebellar Granule Cell Proliferation.
Hor CHH; Lo JCW; Cham ALS; Leong WY; Goh ELK
J Neurosci; 2021 Aug; 41(32):6850-6863. PubMed ID: 34210780
[TBL] [Abstract][Full Text] [Related]
56. Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma.
Merk DJ; Ohli J; Merk ND; Thatikonda V; Morrissy S; Schoof M; Schmid SN; Harrison L; Filser S; Ahlfeld J; Erkek S; Raithatha K; Andreska T; Weißhaar M; Launspach M; Neumann JE; Shakarami M; Plenker D; Marra MA; Li Y; Mungall AJ; Moore RA; Ma Y; Jones SJM; Lutz B; Ertl-Wagner B; Rossi A; Wagener R; Siebert R; Jung A; Eberhart CG; Lach B; Sendtner M; Pfister SM; Taylor MD; Chavez L; Kool M; Schüller U
Dev Cell; 2018 Mar; 44(6):709-724.e6. PubMed ID: 29551561
[TBL] [Abstract][Full Text] [Related]
57. Insulin receptor substrate 1 is an effector of sonic hedgehog mitogenic signaling in cerebellar neural precursors.
Parathath SR; Mainwaring LA; Fernandez-L A; Campbell DO; Kenney AM
Development; 2008 Oct; 135(19):3291-300. PubMed ID: 18755774
[TBL] [Abstract][Full Text] [Related]
58. Genetic ablation of Gpr37l1 delays tumor occurrence in Ptch1
Di Pietro C; La Sala G; Matteoni R; Marazziti D; Tocchini-Valentini GP
Exp Neurol; 2019 Feb; 312():33-42. PubMed ID: 30452905
[TBL] [Abstract][Full Text] [Related]
59. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth.
Hatton BA; Knoepfler PS; Kenney AM; Rowitch DH; de Alborán IM; Olson JM; Eisenman RN
Cancer Res; 2006 Sep; 66(17):8655-61. PubMed ID: 16951180
[TBL] [Abstract][Full Text] [Related]
60. Mutations in SUFU predispose to medulloblastoma.
Taylor MD; Liu L; Raffel C; Hui CC; Mainprize TG; Zhang X; Agatep R; Chiappa S; Gao L; Lowrance A; Hao A; Goldstein AM; Stavrou T; Scherer SW; Dura WT; Wainwright B; Squire JA; Rutka JT; Hogg D
Nat Genet; 2002 Jul; 31(3):306-10. PubMed ID: 12068298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]